Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epinephrine for Visualization in Shoulder Arthroscopy
NCT05244525Phase 4Completed
- Sponsor
- UTHealth Houston
- Start
- Mar 2022
- Primary completion
- Aug 2022
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of epinephrine in shoulder arthroscopy (2 arms), sponsored by UTHealth Houston. Primary endpoints: Surgeon-rated Visual Clarity as Assessed by the Visual Analog Scale and Percentage of Participants for Whom Intra-operative Arthroscopic Pump Pressure Was Increased to 45mmHg or Higher During the Surgical Procedure. Started Mar 2022; status: completed.
02
Drugs
epinephrine
03
Conditions
shoulder arthroscopy
Beyond the preview
Go deeper on NCT05244525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05244525.